AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 32 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,265,000 | -2.2% | 1,285,000 | -0.4% | 0.18% | +2.8% |
Q3 2018 | $1,294,000 | -5.7% | 1,290,000 | -5.5% | 0.18% | -15.6% |
Q2 2018 | $1,372,000 | -99.9% | 1,365,000 | -0.7% | 0.21% | -9.8% |
Q1 2018 | $1,474,811,000 | +6.1% | 1,375,000 | -1.1% | 0.24% | +4.9% |
Q4 2017 | $1,390,542,000 | -7.8% | 1,390,000 | -2.5% | 0.22% | -14.5% |
Q3 2017 | $1,508,961,000 | +0.9% | 1,425,000 | -0.3% | 0.26% | -7.1% |
Q2 2017 | $1,495,566,000 | -3.9% | 1,430,000 | 0.0% | 0.28% | -6.6% |
Q1 2017 | $1,556,598,000 | -25.9% | 1,430,000 | -3.4% | 0.30% | -30.4% |
Q4 2016 | $2,099,558,000 | +23.3% | 1,480,000 | -2.0% | 0.43% | +21.6% |
Q3 2016 | $1,702,676,000 | +1.0% | 1,510,000 | -1.0% | 0.36% | -7.8% |
Q2 2016 | $1,686,391,000 | -10.0% | 1,525,000 | -0.3% | 0.39% | -14.2% |
Q1 2016 | $1,873,454,000 | +96469.8% | 1,530,000 | -0.6% | 0.45% | -10.7% |
Q4 2015 | $1,940,000 | -73.6% | 1,540,000 | -51.6% | 0.50% | -77.3% |
Q3 2015 | $7,340,000 | – | 3,180,000 | – | 2.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 42,500,000 | $43,297,000 | 3.73% |
Mohican Financial Management, LLC | 6,000,000 | $6,056,000 | 2.34% |
GRACE BROTHERS MANAGEMENT LLC | 1,750,000 | $1,781,000 | 1.66% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 34,520,000 | $34,986,000 | 1.43% |
SILVERBACK ASSET MANAGEMENT LLC | 12,250,000 | $12,472,000 | 0.88% |
Man Investments (CH) AG | 1,800,000 | $1,845,000 | 0.74% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 5,000,000 | $510,380,000,000 | 0.58% |
WOLVERINE ASSET MANAGEMENT LLC | 21,109,000 | $21,536,000 | 0.46% |
Wellesley Asset Management | 6,611 | $6,707,000 | 0.43% |
DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,000,000 | $1,013,000 | 0.40% |